Meanwhile, in HCV-related HCC, activated mast cells can transfer exosomal miR-490 to cancer cells and restrain the EGFR/Akt/ERK1/2 pathway to shuttle HCC metastasis [79]. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.